FREE Daily Stock Alerts From Stock-PR.com
HONDO MINERALS CORP (OTCPK:HMNC)
Gold is a yellow soft malleable metal considered valuable, both as an investment and as an adornment. Chemically, gold does not react with most chemicals, but is affected by chlorine, fluorine, aqua regia and cyanide. Gold dissolves in mercury, forming amalgam alloys, but does not react with it. Gold is insoluble in nitric acid, which will dissolve silver and base metals, and this is the basis of the gold refining technique known as "inquartation and parting". Nitric acid has long been used to confirm the presence of gold in items, and is the origin of the colloquial term "acid test," referring to a gold standard test for genuine value.
Hondo Minerals Corporation is engaged in the acquisition of mines, mining claims and mining real estate in the United States, Canada and Mexico with mineral reserves of precious metals or non-ferrous metals.
Hondo owns the Tennessee and Schuylkill Mines in Chloride, Arizona. The Tennessee Mine was the largest producing silver mine in Arizona history. The Tennessee Mine operated from the late 1800's until 1947 producing lead, zinc, gold and silver. The Company also owns numerous other mining claims in the US Southwest, which are being evaluated for additional reserves.
HONDO MINERALS CORP (OTCPK:HMNC) is pleased to announce that it has just acquired over $500,000 dollars of additional E-Leech equipment for its Tennessee Mine production facility.
William R. Miertschin Chairman and CEO of Hondo Minerals says, "This purchase a long with the $2.4 million dollars of previously announced equipment demonstrates our continued efforts to invest real dollars in this project to increase shareholder value."
Mr. Miertschin went on to say, "All of this newly acquired equipment will allow the company the ability to reach its production and revenue targets 6 to12 months ahead of schedule, and with the advanced technology of E-Leech Hondo Minerals is posed to set new standards while obtaining optimum results from its exclusively licensed mining process."
E-Leech technology is a patent pending process that creates a leaching process without the use of hazardous chemicals such as cyanide at its Tennessee Mine processing plant.
Toxic chemicals previously used such as Hydrochloric and Nitric Acid are replaced with a water-based and pH adjusted medium to leach precious and base metals from mine tailings that is safe to humans and the environment.
Electrochemical processes are used to generate pH levels low enough to leach metals such as Gold, Silver, Zinc and Rare Earths into a solution for recovery at an extremely low cost per ton.
For more information please visit: http://www.hondominerals.com
Pan American Silver Corp. (Nasdaq:PAAS) announced that the Company's Board of Directors has approved the second quarterly dividend of 2011. The cash dividend, in the amount of $0.025 per share, will be distributed on or about Wednesday, June 15, 2011, to holders of record of common shares as of the close of business on Tuesday, May 31, 2011. Specific distribution dates and amounts of future dividends will be determined by the Board on an ongoing basis.
Pan American Silver Corp. engages in the exploration, development, extraction, processing, production, refining, reclamation, and operation of silver properties. The company also produces and sells gold, zinc, lead, and copper.
HSN, Inc. (Nasdaq:HSNI) announced that the company's Chief Executive Officer, Mindy Grossman, and Chief Financial Officer, Judy Schmeling, will participate in the Piper Jaffray 31st Annual Consumer Conference in New York City, on Wednesday, June 8, 2011 at 9:50 am ET. The format of the session will be a Fireside Chat. To listen to a live broadcast of both presentations, please visit the investor section of the company's website at www.hsni.com. For those unable to participate, an archived broadcast will be available shortly following the presentation.
HSN, Inc. markets and sells a range of third party and private label merchandise primarily in the United States. The company offers jewelry, beauty and wellness products, housewares, home fashions, electronics, and fitness and other products directly to consumers through the HSN television network and HSN.com Web site.
Foster Wheeler AG (Nasdaq:FWLT) announced that Umberto della Sala, interim chief executive officer of Foster Wheeler AG, will make a presentation to investors at the Credit Suisse Engineering & Construction Conference in New York City on Thursday, June 2, 2011 at 11:10 a.m. (Eastern). Foster Wheeler invites investors and those interested to listen to a live audio webcast and view presentation slides via the Investor Relations Presentations section of the company's website (www.fwc.com).
Foster Wheeler AG, together with its subsidiaries, provides construction and engineering services to the oil and gas, oil refining, chemical/petrochemical, pharmaceutical, environmental, power generation, and power plant operation and maintenance industries worldwide.
Power 3 Medical Products Inc. (OTC:PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
The NuroPro Blood Test of Power3 Medical Products, Inc is a diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases would allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
Patients with Alzheimer's disease first lose such mental functions as short-term memory and the ability to learn new things. In the later stages of AD they gradually lose control over their sense of orientation, their emotions, and other aspects of behavior. End-stage AD is characterized by loss of control of body functions, an increased likelihood of seizures , loss of the ability to eat or swallow, and eventual death from infection or malnutrition. Alzheimer's disease is the most common cause of dementia (loss of cognitive abilities) in the elderly; it is thought to be responsible for 50%-70% of cases of dementia in the United States.
For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty five thousand dollars ($25,000) in cash from a third party (Friona Gold, LLC) for 1 week of media advertisement services for Hondo Minerals Corporation (OTCPK:HMNC) Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup